ExodusPoint Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.13M | Buy |
72,599
+70,185
| +2,907% | +$8.82M | 0.08% | 229 |
|
2025
Q1 | $267K | Sell |
2,414
-13,430
| -85% | -$1.49M | ﹤0.01% | 1190 |
|
2024
Q4 | $2.16M | Buy |
+15,844
| New | +$2.16M | 0.01% | 630 |
|
2024
Q3 | – | Sell |
-13,304
| Closed | -$1.83M | – | 1794 |
|
2024
Q2 | $1.83M | Sell |
13,304
-24,050
| -64% | -$3.31M | 0.01% | 703 |
|
2024
Q1 | $5.15M | Sell |
37,354
-8,710
| -19% | -$1.2M | 0.04% | 296 |
|
2023
Q4 | $6.07M | Buy |
46,064
+14,276
| +45% | +$1.88M | 0.04% | 272 |
|
2023
Q3 | $3.58M | Sell |
31,788
-84,917
| -73% | -$9.55M | 0.03% | 431 |
|
2023
Q2 | $11M | Sell |
116,705
-57,295
| -33% | -$5.4M | 0.09% | 200 |
|
2023
Q1 | $17.6M | Buy |
174,000
+100,994
| +138% | +$10.2M | 0.15% | 120 |
|
2022
Q4 | $8.72M | Buy |
73,006
+22,025
| +43% | +$2.63M | 0.13% | 193 |
|
2022
Q3 | $5.42M | Sell |
50,981
-12,207
| -19% | -$1.3M | 0.07% | 352 |
|
2022
Q2 | $6.16M | Buy |
63,188
+16,066
| +34% | +$1.57M | 0.08% | 314 |
|
2022
Q1 | $4.42M | Sell |
47,122
-19,618
| -29% | -$1.84M | 0.06% | 395 |
|
2021
Q4 | $5.68M | Buy |
66,740
+40,867
| +158% | +$3.48M | 0.06% | 367 |
|
2021
Q3 | $2.48M | Sell |
25,873
-29,521
| -53% | -$2.83M | 0.03% | 602 |
|
2021
Q2 | $5.39M | Buy |
+55,394
| New | +$5.39M | 0.06% | 289 |
|
2021
Q1 | – | Sell |
-6,983
| Closed | -$669K | – | 2367 |
|
2020
Q4 | $669K | Sell |
6,983
-11,840
| -63% | -$1.13M | 0.01% | 1009 |
|
2020
Q3 | $1.81M | Sell |
18,823
-7,353
| -28% | -$707K | 0.04% | 400 |
|
2020
Q2 | $3.19M | Sell |
26,176
-2,913
| -10% | -$355K | 0.08% | 261 |
|
2020
Q1 | $2.52M | Buy |
+29,089
| New | +$2.52M | 0.14% | 120 |
|
2019
Q4 | – | Sell |
-44,746
| Closed | -$4.03M | – | 1699 |
|
2019
Q3 | $4.03M | Buy |
44,746
+6,907
| +18% | +$622K | 0.14% | 124 |
|
2019
Q2 | $3.2M | Sell |
37,839
-14,219
| -27% | -$1.2M | 0.13% | 91 |
|
2019
Q1 | $4.59M | Buy |
52,058
+37,225
| +251% | +$3.28M | 0.34% | 48 |
|
2018
Q4 | $1.06M | Buy |
+14,833
| New | +$1.06M | 0.07% | 80 |
|